Enersys (ENS) Drops 7.31% on January 25

Equities Staff |

Enersys (ENS) was one of the Russell 2000's biggest losers for Monday January 25 as the stock slid 7.31% to $48.56, a loss of $-3.83 per share. Starting at an opening price of $51.73 a share, the stock traded between $47.70 and $51.86 over the course of the trading day. Volume was 366,433 shares over 3,352 trades, against an average daily volume of 359,896 shares and a total float of 44.4 million.

The losses send Enersys down to a market cap of $2.16 billion. In the last year, Enersys has traded between $73.27 and $49.21, and its 50-day SMA is currently $56.92 and 200-day SMA is $61.25.

The stock has a P/E Ratio of 14.9.

EnerSys manufactures, markets and distributes industrial batteries and related products such as chargers, power equipment and battery accessories. It also provides after-market and customer-support services for industrial batteries.

Enersys is based out of Reading, PA and has some 9,500 employees. Its CEO is John D. Craig.

For a complete fundamental analysis analysis of Enersys, check out Equities.com’s Stock Valuation Analysis report for ENS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…